Search clinical trials for: Atorvastatin

Total 1010 results

Gachon University Gil Medical Center

Completed

Effects of Atorvastatin on Adiponectin Levels and Insulin Sensitivity In Hypercholesterolemic Patients

Hypercholesterolemia

Korea, Republic of
Gachon University Gil Medical Center

Completed

Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension

Hypertension

Korea, Republic of
Ministry of Science and Technology of the People´s...
Peking University First Hospital

Unknown

Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis (EALIPPCA)

Atherosclerosis

China
Ministry of Science and Technology of the People´s...

Unknown

China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome (CHILLAS)

Acute Coronary Syndrome

China
University of Washington
Upsher-Smith Laboratories

Completed

SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia

Dyslipidemia

United States
Hospital Arnau de Vilanova
Pfizer

Unknown

Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases. (PRIMARIA)

Cardiovascular Diseases | Atherosclerosis

Spain
University of Toronto
Pfizer; Unity Health Toronto; Canadian Heart Research Centre; Ontario Association... and other collaborators

Unknown

Atorvastatin for the Treatment of Retinal Vein Occlusion (ATORVO)

Thrombosis | Central Retinal Vein Occlusion | Retinal Vein Occlusion | Branch Retinal Vein Occlusion | Retinal Vein Thrombosis

Canada
Amsterdam UMC, location VUmc

Unknown

Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin. (SOS)

Hypertension | Diabetes Mellitus

Netherlands
McGill University Health Centre/Research Institute...

Completed

High-Density Lipoprotein (HDL) Treatment Study

Genetic Diseases, Inborn | Coronary Arteriosclerosis | Hypoalphalipoproteinemias

Canada
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Dyslipidemia

Netherlands
DiObex

Terminated

Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

Type 2 Diabetes

Australia, United States, New Zealand
R&D Cardiologie
UMC Utrecht

Completed

Myocardial Infarction Size Reduction With Atorvastatin

Myocardial Infarction | Reperfusion Injury

Netherlands
Children's Mercy Hospital Kansas City

Completed

Atorvastatin (Lipitor) to Prevent Bone Pain

Osteoporosis

United States
Regional Hospital Holstebro

Completed

The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake

Healthy Subjects

Denmark
Regional Hospital Holstebro

Completed

Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

Healthy

Denmark
Regional Hospital Holstebro

Completed

Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

Healthy

Denmark
Regional Hospital Holstebro
Medical Research

Completed

The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes

Healthy Subjects

Denmark
Poznan University of Medical Sciences
University of California, Davis; Biomet Polska Sp. z.o.o.

Unknown

Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis (EndoStatin)

Pain | Endometriosis

Poland
Bayhill Therapeutics

Completed

Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

Multiple Sclerosis

United States, Canada
The University of Western Australia
National Heart Foundation, Australia

Completed

Pharmacological Regulation of Fat Transport in Metabolic Syndrome

Obesity | Cardiovascular Disease | Hypertriglyceridemia | Lipid Disorders
Pfizer

Terminated

Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies

Cerebrovascular Disorders | Cardiovascular Disease

United States
Samsung Medical Center

Completed

Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery

Coronary Artery Bypass

Korea, Republic of
Nabi Biopharmaceuticals

Completed

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

Arteriosclerosis | Hyperparathyroidism, Secondary | Calcinosis

United States
AstraZeneca

Completed

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

France, Italy, Spain, Estonia, Hungary, Canada, Belgium, Portugal, Greece, Ireland, Tunisia
Medical University of Gdansk

Completed

Optimalization of Nephroprotection Using Atorvastatin (Sortis)

Proteinuria | Chronic Kidney Disease
Pfizer

Terminated

A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

Dyslipidemia | Hyperlipidemia

United States
Pfizer

Completed

A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease (ILLUSTRATE)

Coronary Disease | Coronary Arteriosclerosis | Hyperlipidemia

United States, Spain, Canada, Poland, Belgium, Netherlands
Pfizer

Completed

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.

Dyslipidemia | Hypercholesterolemia | Hyperlipidemia

United States
University Hospital Muenster

Withdrawn

Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques

Atherosclerosis
Pfizer

Completed

A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

Hypertriglyceridemia | Hyperlipoproteinemia Type IV

United States, Canada
Pfizer

Completed

Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

Hyperlipidemia

United States, Canada
Pfizer

Completed

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

Hypercholesterolemia, Familial

Canada, United States, South Africa
Pfizer

Completed

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

Hyperlipidemia

France
Pfizer

Completed

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

Hyperlipidemia | Hypercholesterolemia, Familial

Australia, Canada, United States, France, South Africa, Sweden, Norway, Denmark, Iceland
Skane University Hospital

Completed

Atorvastatin in Moderate Active Crohns Disease

Crohns Disease

Sweden
Abbott

Completed

A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

Hyperlipidemia
Baskent University

Completed

Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition

Cardiovascular Disease | Type 2 Diabetes Mellitus | Cognition | LDL Cholesterol
Masaryk University

Unknown

Study of Influence of Atorvastatin on the Repolarisation Phase of Cardiomyocytes (ATORVA)

Heterogeneity of Cardiomyocytes Repolarisation | Autonomic Changes of Cardiomyocytes Repolarisation
Pfizer
Diabetes UK; Department of Health, United Kingdom

Completed

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events (CARDS)

Angina, Unstable | Cerebrovascular Accident | Coronary Artery Bypass Graft | Revascularization | Major Coronary Event

United Kingdom
Yokohama City University Medical Center

Completed

Effects of Atorvastatin Versus Probucol on Small Dense LDL

Chronic Nephropathy

Japan
Pfizer

Completed

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels (TNT)

Cardiovascular Disease | Coronary Heart Disease | Cerebrovascular Accident

United States, Australia, Netherlands, Canada, Spain, France, Austria, Italy, South Africa, Belgium, Germany, Switzerland, Ireland, United Kingdom
Brigham and Women's Hospital

Completed

The Effects of Atorvastatin in Patients With Atherosclerosis

Atherosclerosis

United States
Brigham and Women's Hospital

Completed

Rho Kinase in Patients With Atherosclerosis

Atherosclerosis

United States
Eli Lilly and Company

Completed

A Study in People With High Cholesterol

Hypercholesterolemia

United States
Johns Hopkins University
Lupus Research Alliance

Completed

Lupus Atherosclerosis Prevention Study

Systemic Lupus Erythematosus

United States
Buddhist Tzu Chi General Hospital
Pfizer

Unknown

An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Taiwan
Radboud University Medical Center
Pfizer; Schering-Plough

Completed

Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients (SPACE)

Inflammation | Atrial Fibrillation | Magnetic Resonance Imaging | Hemostasis | Neuropsychology

Netherlands
Abant Izzet Baysal University

Unknown

A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis

Diabetes Mellitus | Hypercholesterolemia | Coronary Heart Disease | Non-Coronary Atherosclerotic Disease

Turkey
Pfizer

Completed

This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.

Coronary Arteriosclerosis

United States
Massachusetts General Hospital

Completed

Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus

Hepatitis C

United States

Search clinical trials for: Atorvastatin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations